Delivery Order SPE2DB22D2005-SPE2DB25FJRY8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,747.80 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,435.95 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12 grams) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,438.62 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on September 15, 2025, with completion expected by September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $19,014.36 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Advair HFA 115-21 micrograms inhalers (12-gram units) with a ceiling value of $2,208.80. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,766.80 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction within the...
- The Defense Logistics Agency awarded a $48,669.45 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 26, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal pharmaceutical...
- The Defense Logistics Agency awarded a $2,965.10 delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed openly among qualified vendors. This delivery...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRY8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,648.38 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 grams) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a routine pharmaceutical supply delivery to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion value through December 2026. That prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and other healthcare commodities to military and federal healthcare systems worldwide. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen regularly fulfills federal medical supply requirements across multiple therapeutic domains and maintains a demonstrated capability to compete successfully for Department of Defense healthcare procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/18/25 |